These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 11375785

  • 1. The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation.
    Chow GK, Myles J, Novick AC.
    Can J Urol; 2001 Apr; 8(2):1223-8. PubMed ID: 11375785
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S, Ioritani N, Oikawa K, Aizawa M, Endoh M, Arai Y.
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC.
    Urol Oncol; 2005 Aug; 23(5):328-32. PubMed ID: 16144666
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG, Cherullo E, Myles J, Novick AC.
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [Abstract] [Full Text] [Related]

  • 16. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS.
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [Abstract] [Full Text] [Related]

  • 17. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 18. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [Abstract] [Full Text] [Related]

  • 19. Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b).
    Klaver S, Joniau S, Suy R, Oyen R, Van Poppel H.
    BJU Int; 2008 Feb; 101(4):444-9. PubMed ID: 18021278
    [Abstract] [Full Text] [Related]

  • 20. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.